Altogether, our findings suggest that EHF is a novel functional oncogene in thyroid cancer by transcriptionally regulating HER2 and HER3, and may represent a potential therapeutic target for this cancer. This evidence concerns the gene ERBB3 and thyroid gland carcinoma.